+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cortisol receptor resistance: the variability of its clinical presentation and response to treatment



Cortisol receptor resistance: the variability of its clinical presentation and response to treatment



Journal of Clinical Endocrinology and Metabolism 74(2): 313-321



Primary (partial) cortisol receptor resistance was previously reported in a total of 7 patients and 14 asymptomatic family members. Its occurrence is considered to be extremely rare. In the present study we report on 6 patients (2 males and 4 females) with the syndrome. The first male patient presented with mild hypertension. Hydrochlorothiazide therapy resulted in life-threatening hypokalemia. The second male patient had slight hypertension without hypokalemia. All four female patients presented between the age of 20-30 yr with acne, hirsutism, and irregular menstruations. Low dose dexamethasone therapy (1-1.5 mg/day) was of clinical benefit in these patients. All patients showed insufficient suppression of serum cortisol concentrations in the overnight 1-mg dexamethasone test. The diurnal rhythm of ACTH and cortisol was intact, albeit at an elevated level. There was a normal increase in ACTH, cortisol, and GH (except in one obese patient) in response to insulin-induced hypoglycemia, while cortisol production was elevated in three patients. Circulating adrenal androgen levels were increased in all patients. Glucocorticoid receptors were investigated in a whole cell dexamethasone binding assay in mononuclear leukocytes. In the first male patient, the number of receptors was very low, while the affinity was lower than that in controls. A lowered affinity to dexamethasone was found in one female patient, while a lowered number of receptors was found in three patients. In the second male patient, no abnormalities were found. As a bioassay for glucocorticoid action we also measured dexamethasone suppressibility of mitogen-stimulated incorporation of [3H]thymidine in mononuclear leukocytes. In the male patient with normal receptor status, dexamethasone suppressibility of [3H]thymidine incorporation was significantly lower than that in healthy controls with respect to both maximal suppression and IC50. Partial cortisol receptor resistance might be less rare than previously thought. In the six patients presented, at least three different forms can be recognized. Therapy with dexamethasone was successful in female patients with acne and hirsutism, as the secondary increase in the production of adrenal androgens was effectively controlled.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 007165380

Download citation: RISBibTeXText

PMID: 1309833

DOI: 10.1210/jcem.74.2.1309833


Related references

Variability in the clinical presentation of Pompe disease in infancy: two case reports and response to treatment with human recombinant enzyme. Revista de Neurologia 59(11): 503-507, 2015

Does clinical presentation explain practice variability in the treatment of febrile infants?. Pediatrics 117(3): 787-795, 2006

Variability in the clinical presentation of autism issues of diagnosis and treatment in the preschool years. Amir, N , I Rapin And D Branski (Ed ) Pediatric And Adolescent Medicine, Vol 1 Pediatric Neurology: Behavior And Cognition Of The Child With Brain Dysfunction X+186p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 36-49, 1991

Estrogen receptor status and the clinical response to a combination of aminoglutethimide and cortisol in advanced breast cancer. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 91: 248-252, 1984

Study of variability in response to aspirin and clopidogrel: clinical and/or biological resistance?. Annales Pharmaceutiques Francaises 67(4): 265-271, 2009

5HT1A-mediated stimulation of cortisol release in major depression: use of non-invasive cortisol measurements to predict clinical response. European Archives of Psychiatry and Clinical Neuroscience 260(2): 175-180, 2010

Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment. Schizophrenia Research 116(2-3): 234-242, 2010

Catatonia in DSM 5: controversies regarding its psychopathology, clinical presentation and treatment response. Neuropsychopharmacologia Hungarica 16(4): 189-194, 2015

Clinical presentation of posttransplant lymphoproliferative disorders and response to treatment. Blood 94(10 SUPPL 1 PART 1): 514a, Nov 15, 1999

Effect of obesity on clinical presentation and response to treatment in asthma. Journal of Asthma 43(7): 553-558, 2006

Congenital intraspinal lipomas: clinical presentation and response to treatment. Journal of Pediatric Orthopedics 7(5): 531-537, 1987

Does a family history of RA influence the clinical presentation and treatment response in RA?. Annals of the Rheumatic Diseases 75(6): 1120-1125, 2015

Burnout and cortisol: evidence for a lower cortisol awakening response in both clinical and non-clinical burnout. Journal of Psychosomatic Research 78(5): 445-451, 2015

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108(4): 1267-1279, 2006

Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients. Journal of the American Academy of Dermatology 69(4): 557-564, 2013